Research Papers:

Long term storage in liquid nitrogen leads to only minor phenotypic and gene expression changes in the mammary carcinoma model cell line BT474

PDF |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2017; 8:35076-35087. https://doi.org/10.18632/oncotarget.16623

Metrics: PDF 1397 views  |   HTML 1799 views  |   ?  

Judit Fazekas, Thomas W. Grunt, Erika Jensen-Jarolim and Josef Singer _


Judit Fazekas1,2, Thomas W. Grunt3, Erika Jensen-Jarolim1,2 and Josef Singer2,4

1Comparative Medicine, The Interuniversity Messerli Research Institute of the University of Veterinary Medicine Vienna, Medical University of Vienna and University of Vienna, Vienna, Austria

2Institute of Pathophysiology and Allergy Research, Center of Physiology, Pathophysiology and Immunology, Medical University of Vienna, Vienna, Austria

3Comprehensive Cancer Center, Department of Medicine I & Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna, Austria

4Department of Internal Medicine II, University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems, Austria

Correspondence to:

Josef Singer, email: josef.singer@meduniwien.ac.at

Keywords: long term storage in liquid nitrogen, cell line stability, BT474 cells, gene expression, EGFR

Received: October 04, 2016     Accepted: March 08, 2017     Published: March 28, 2017


Background/Aim: Cancer cell lines are indispensible surrogate models in cancer research, as they can be used off-the-shelf, expanded to the desired extent, easily modified and exchanged between research groups for affirmation, reproduction or follow-up experiments.

As malignant cells are prone to genomic instability, phenotypical changes may occur after certain passages in culture. Thus, cell lines have to be regularly authenticated to ensure data quality. In between experiments these cell lines are often stored in liquid nitrogen for extended time periods.

Although freezing of cells is a necessary evil, little research is performed on how long-term storage affects cancer cell lines. Therefore, this study investigated the effects of a 28-year long liquid nitrogen storage period on BT474 cells with regard to phenotypical changes, differences in cell-surface receptor expression as well as cytokine and gene expressional variations.

Methods: Two batches of BT474 cells, one frozen in 1986, the other directly purchased from ATCC were investigated by light microscopy, cell growth analysis, flow cytometry and cytokine as well as whole-transcriptome expression profiling.

Results: The cell lines were morphologically indifferent and showed similar growth rates and similar cell-surface receptor expression. Transcriptome analysis revealed significant differences in only 26 of 40,716 investigated RefSeq transcripts with 4 of them being up-regulated and 22 down-regulated.

Conclusion: This study demonstrates that even after very long periods of storage in liquid nitrogen, cancer cell lines display only minimal changes in their gene expression profiles. However, also such minor changes should be carefully assessed before continuation of experiments, especially if phenotypic alterations can be additionally observed.


Cancer cell lines represent important surrogate models in cancer research [1] as primary malignant tissues are often very hard to access. Moreover, primary cancer tissue features high patient-to-patient heterogeneity, is hard to store and can often be acquired in small sample sizes only.

Cancer cell lines, however, can be used off-the-shelf, expanded to the desired quantity, easily transfected with genes of interest and can be widely distributed between laboratories and institutions in order to allow others to reproduce or continue experiments.

This routine includes numerous cycles of freezing and thawing. Considering that malignant cells need many mutations to gain the ability to grow outside the body as well as to gain immortality in this condition, these cell lines have very instable genomes [2]. Thus, these cells are very vulnerable for new mutations [3] with high potential to lose key features of the originally described cell line [4].

Even more disturbing are repeated reports of interchanged or cross-contaminated cell lines [56], which in some cases can be traced back for decades [7], annihilating research results of several years.

The International Cell Line Authentication Committee maintains a database on misidentified cell lines, which can be found online at www.iclac.org.

Therefore, international research communities have implemented guidelines for publication of cell line experiments [8]. Although these guidelines differ to some extent between scientific journals, all of them require cell lines to be authenticated in regular intervals. Cell line authentication methods comprise of short tandem repeat profiling (STR, [9]) as well as single nucleotide polymorphism arrays (SNP, [1011]). Both methods are highly reliable, except in the case of mismatch repair deficient cell lines, which display microsatellite instability and therefore allelic drifts could be forced; if additionally selective outgrowth of otherwise persisting side lines occurs, STR-profiling can be misleading [11].

Nevertheless, in general, both authentication methods have helped to drastically reduce misleading results due to cross-contamination, or the fact that the surrogate model based on a respective cancer cell line is not valid any more, as the cell line has changed its phenotype substantially.

Another important point, however, which is not that thoroughly investigated yet, is the fact, that between experiments cell lines are stored in liquid nitrogen for very long periods of time. These storage conditions are completely unphysiological for cells. In order to reduce freezing damage, the addition of dimethyl sulphoxide (DMSO) to the freezing medium was already recommended by Lovelock & Bishop back in 1959 [12]. Since then, numerous efforts have been exerted to improve the viability of cells after the thawing process (reviewed in [13]).

Although it is unlikely that during storage mutations occur, it is not yet closely investigated to which extent changes in gene expression can occur. Only sporadic papers describe functional changes after cryopreservation, e.g. changes in IL-6 secretion of an adenocarcinoma cell line [14] or upregulation of caspase-3 in fibroblasts [15].

Thus, this study aims to investigate possible phenotypic changes, differences in cell surface receptor expression as well as cytokine and gene expression-variations of a standard breast cancer cell line, BT474 [16], after long-term storage in liquid nitrogen. We investigated two batches of BT474 cells, one directly purchased from the American Type Culture Collection (ATCC) and the other stored for 28 years in a research laboratory’s liquid nitrogen tank.


Cell line authentication

Cell lines were sent to cell line authentication prior to the experiments. Firstly, short nucleotide polymorphism (SNP) - profiling was performed. Here, 24 gene loci were analysed; only if at least 22 loci can be amplified, DNA quality is rated “ok”, which was the case for both tested samples. As can be seen in Table 1, the SNP screening confirmed the identity of both cell lines with identical genotype codes and detected no cross-contamination.

Table 1: Cell line authentication reports of SNP profiling

Sample Name

Cell line name

DNA quality

Best Hit with DataBase

Identity (%)

Present in Database?


Identity confirmed?

Genotype Code








identity confirmed


BT474 1986







identity confirmed


SNP authentication confirmed the identity of both tested BT474 cell line batches and excluded cross-contamination in both.

In order to gain data on short tandem repeat (STR) profiles of both cell lines too, another round of cell line authentication was performed. As depicted in Table 2, also here both cell lines were clearly identified as BT474 cells with all tested loci matching the reference data.

Table 2: Cell line authentication reports of STR profiling

Powerplex16 Loci

Database Reference BT474


BT474 1986
















28, 32.2

















































All tested gene matched in both BT474 ATCC as well as BT474 1986 cells. The database reference is taken from ATCC; as ATCC uses a 9 gene loci profile only, some loci are left empty.

Transmitted light microscopy

Cells were regularly observed under transmitted light microscopy for eventual phenotypic changes. As can be seen in Figure 1, BT474 cells are adherent, “cobblestone-shaped” and grow in clusters that form compact multilayered colonies, rather than growing confluent. Both cell lines displayed similar phenotypes and formed exactly these multilayered colonies.

Transmitted light microscopy of BT474 cells.

Figure 1: Transmitted light microscopy of BT474 cells. Both BT474 cell clones display adherent growth, are “cobblestone-shaped” and grow in clusters that form compact multilayered colonies. Top row: 20x magnification, bottom row: 40x magnification.

Cell growth analysis

In order to detect possible differences in the proliferation rate of the BT474 ATCC and BT474 1986 cell lines, cell growth was analysed. Again, both cell lines behaved similarly, with no statistical differences in cell numbers after 12, 24, 48 or 70 hours (Figure 2).

Cell growth analysis.

Figure 2: Cell growth analysis. Both BT474 cell clones grow at a similar rate, with no statistical differences in cell numbers at 12, 24, 48 and 70 hours after seeding.

Cell surface marker expression and cytokine analysis

In order to further investigate whether also cell surface receptor expression remains stable after such a long storage in liquid nitrogen, human epidermal growth factor receptor-1 (EGFR) and human epidermal growth factor receptor-2 (HER-2) expression was determined, as these cells are most often used for modeling HER-2 or EGFR-driven disease. As can be seen in Figure 3, again both BT474 cells, the ones from ATCC as well as the ones frozen in 1986 showed comparable EGFR and HER-2 expression, indicating no influence of the storage on the expression of these two epidermal growth factor receptors. Furthermore, 34 different cytokines, chemokines and growth factors were analyzed. Here, supernatants of cells 48 hours in culture were investigated via Luminex®. As depicted in Figure 4, only IL-1α, IL-1RA (IL-1 Receptor Antagonist), IL-7, IL-8, IL-9, MCP-1, RANTES, SDF-1α and TNF-β are secreted by BT474 cells. The levels of all other cytokines were under the detection limit of the assay. Both cell lines displayed again similar profiles with the exception of IL-1RA, where BT474 1986 cells had significantly lower levels.

Flow cytometric analysis of EGFR and HER-2 expression.

Figure 3: Flow cytometric analysis of EGFR and HER-2 expression. (A) Both BT474 cell batches display comparable, moderate EGFR expression as detected with cetuximab. Isotype controls are displayed as full grey histograms, cetuximab stainings as lines. Full lines indicate BT474 ATCC cells and dashed lines indicate BT474 1986 cells. (B) Statistical readout of flow cytometric experiments shown in (A). Bars depict median fluorescence intensity ± standard deviation. No statistically significant differences could be observed between the two investigated BT474 cell lines with regard to EGFR expression. (C) BT474 ATCC and BT474 1986 express high levels of HER-2, detected with trastuzumab. Isotype controls are displayed as full grey histograms, trastuzumab stainings as lines. Full lines indicate BT474 ATCC cells and dashed lines indicate BT474 1986 cells. (D) Statistical readout of flow cytometric experiments shown in (C). Bars depict median fluorescence intensity ± standard deviation. Again no statistically significant differences could be observed between the two investigated BT474 cell lines with regard to HER-2 expression.

Cytokine, chemokine and growth factor analysis.

Figure 4: Cytokine, chemokine and growth factor analysis. 34 different cytokines, chemokines and growth factors were determined in supernatants of BT474 ATCC and BT474 1986 cells 48 hours in culture. Signals could be detected for IL-1α, IL-1RA, IL-7, IL-8, IL-9, MCP-1, RANTES, SDF-1α and TNF-β, with significantly lower levels of IL-1RA in supernatants of BT474 1986 cells.


Finally, the whole transcriptome of both cell lines was investigated by means of RNA-profiling. RNA quality and integrity was assessed twice by means of an Agilent 2100 Bioanalyzer (data not shown) prior to analysis in the GeneChip Human Gene 2.0 ST Array. Afterwards several analysis steps were performed to exclude non-biological factors in the variability of the data of the RNA-screens. Firstly, normalization of the input was performed using quantiles method. As can be seen in Supplementary Figure 1, all chips were compared to each other. After normalization, the red line in the graph should be ideally close to zero (indicated as green line). This was well achieved in all tested samples.

Secondly, hybridization data of each chip was graphically analysed in a box plot to gain information about symmetry or possible skewness of the distribution. In all hybridization experiments, the median line was centered between the upper and lower extent of the box and no skewness was detectable (Supplementary Figure 2).

Thus, gene expression data was subsequently analysed for induced and repressed genes. This analysis revealed that only 4 Reference Sequences (RefSeqs) were up-regulated in the BT474 1986 cells compared to the BT474 ATCC cells. These 4 genes are listed in Table 3, ranked by their absolute fold change.

Table 3: Up-regulated genes, sorted by their absolute fold change


Probe Id

Gene symbol/Gene name


Log(Fold change)

Fold change



[MME] membrane metallo-endopeptidase;
AK291761 AK310664 BC101632
BC101658 BC106070 BC143465 BX647134
ENST00000360490 ENST00000382989
ENST00000460393 ENST00000462745
ENST00000462837 ENST00000481828
ENST00000491026 ENST00000491597
ENST00000492661 ENST00000493237
ENST00000493888 ENST00000495577
J03779 NM_000902 NM_007287 NM_007288
NM_007289 Y00811






[MIR3188] microRNA 3188; NR_036155






[MME MME-AS1] MME antisense RNA 1
(non-protein coding); ENST00000460393
ENST00000484721 J03779 NM_000902
NM_007287 NM_007288 NM_007289






[ME1] malic enzyme 1, NADP(+)-dependent,
cytosolic; BC025246 ENST00000369705
ENST00000540036 ENST00000541327
ENST00000543031 NM_002395




Genes up-regulated in BT474 1986 cells compared to BT474 ATCC cells. Rank indicating position in all differently expressed genes, sorted by absolute fold change.

Accordingly, down-regulated transcripts can be seen in Table 4, again ranked by their absolute fold change. Here, 22 RefSeqs were repressed in the BT474 1986 cells compared to the BT474 ATCC cells.

Table 4: Down-regulated genes, sorted by their absolute fold change


Probe Id

Gene symbol/Gene name


Log(Fold change)

Fold change



[CTGF]; BC087839 ENST00000367976






[miscellaneous] AF269087






[miscellaneous] ENST00000443280






[NRN1] neuritin 1; BC042019
ENST00000244766 ENST00000495850






[C6orf223] AK097853; BC032706
ENST00000336600 ENST00000439969
ENST00000442114 ENST00000448947
NM_001171992 NM_153246






[PNRC2] proline-rich nuclear receptor coactivator
2; ENST00000471915 NM_017761






[miscellaneous] ENST00000416067






[RNU7-13P RNU7-41P] RNA, U7 small nuclear
13 pseudogene; RNA, U7 small nuclear
41 pseudogene; ENST00000515917






[miscellaneous] ENST00000557163;






[miscellaneous] ENST00000416067






[miscellaneous] ENST00000416067






[miscellaneous] ENST00000414084;






[STX19] syntaxin 19; BC034696
ENST00000315099 NM_001001850






[miscellaneous] XM_002342917






[miscellaneous] BX647429






[EGR1] early growth response 1;
ENST00000239938 ENST00000411801
ENST00000535792 M62829 NM_001964






[SNORD59A] small nucleolar RNA, C/D box
59A; NR_002737






[miscellaneous] ENST00000575039;






[miscellaneous] ENST00000466451;






[DKFZp667F0711] ; AL713753






[miscellaneous] ENST00000416067






[miscellaneous] ENST00000426191;




Genes down-regulated in BT474 1986 cells compared to BT474 ATCC cells. Rank indicating position in all differently expressed genes, sorted by absolute fold change.

For better visualization, differently expressed genes were clustered two-dimensionally in a heat map in Figure 5. Here, genes with similar behavior are compiled in vertical clusters.

Heat map displaying two-dimensional clustering of the top genes.

Figure 5: Heat map displaying two-dimensional clustering of the top genes. Different samples are labeled on the x-axis. Y-axis displays differently expressed genes. Genes that fall into a cluster showed similar behavior in the experiments. Intensities of expression are represented by red and green, red standing for up-regulation, green for down-regulation and black indicates medium intensities.

Additionally, data was visualized by means of a Volcano Plot displaying the relation between p-values and log2-fold change (Supplementary Figure 3). The complete list of all signals from the RNA profiling can be found in the supplementary data (Supplementary Table 1).


BT474 cells are routinely used in our laboratory as a model system for HER-2 overexpressing breast cancer. These cells were isolated in 1978 by Lasfargues et al. from a patient with solid, invasive ductal breast carcinoma [16]. Prior to the introduction of this cell line, most human breast cancer cell lines were derived from pleural effusions, which accented BT474 cells as a more valid surrogate for solid tumors. Later, when breast cancer research focused on HER-2, BT474 cells, which highly over-express this receptor, became very important as mimic for HER-2 driven disease [1718]. Moreover, BT474 cells grow well in immunocompromised mice, making this cell line also valuable for in vivo xenograft studies [1921].

If a cell line is constantly used in a lab since 1978, only two variants of currently used clones can exist: a) clones that have been in culture for numerous passages, either constantly, or (more likely) by means of repeated freezing and thawing or b) clones that have been frozen originally as master stock and were stored for long periods of time. For the first variant, a great deal of investigation was performed to evaluate the effects of repeated cell divisions as well as effects of freezing and thawing on cell lines. On the latter condition only little research has been performed, most likely because it is not so easy to access cell clones that have been in the same liquid nitrogen container for more than 20 years.

Fortunately, we could get access to a BT474 clone, which has been stored for 28 years under optimal conditions, not harmed by unforeseeable events such as e.g. electrical breakdowns, relocation of laboratory space or being discarded when research topics change.

Our internal cell line quality control standards comprise of regular authentication via SNP profiling. In this particular case with such a long history of storage, however, we did not want to solely rely on one authentication run. That is why we analyzed this cell clone also by STR profiling and thoroughly monitored growth behavior, eventual phenotypic changes, as well as cell surface receptor expression. As these parameters were stable (Table 1, 2; Figures 1, 2 & 3), we decided to further investigate possible changes in gene expression via a human RNA profile array.

Interestingly, only 4 reference sequences were significantly induced in the ‘1986’ clone (see Table 3), among these MME (membrane metallo-endopeptidase, or neprilysin and CD10, as it is alternatively termed), which is linked to higher tumor grade and poor prognosis upon expression in invasive breast carcinoma [22]. Interestingly, also the MME-antisense RNA 1 was induced, too.

Another up-regulated gene encodes the NADP(+) dependent cytosolic malic enzyme, which is physiologically found in liver and white adipose tissue [23], but was also described in human breast, colon, lung and lymphoid cancer cell lines, where it is involved in the conversion of excess mitochondrial malate [24]. The last induced RNA sequence was the microRNA3188, which has been described in melanoma [25].

By contrast, 22 reference sequences were repressed; the gene, which showed the highest fold change overall was CTGF (connective tissue growth factor), which was more than 6-fold down-regulated. CTGF can induce tumor cell epithelial-mesenchymal transition (EMT) in breast cancer, and is able to promote tumor growth and metastasis, resulting in poor clinical outcomes [26]. The second most down-regulated gene was neuritin 1 (NRN1), which has been proposed as hypoxic marker and potential marker for tumor angiogenesis [27], followed by the proline-rich nuclear receptor coactivator 2 (PNRC2), syntaxin 19, and early growth response 1 (EGR1). Syntaxin 19 (or epimorphin, as it is also termed) was at least in the murine system associated with the promotion of alveolar hyperplasia and mammary adenocarcinoma [28]. Also EGR1 was described to be involved in breast tumorigenesis via transcriptional control of miR-20b, which can function as an oncogene via tumor suppressor targeting [29].

Additonally, a small nuclear pseudogene, RNU7-13P and a small nucleolar RNA were repressed. The last 15 down-regulated RNAs were the Chromosome 6 Open Reading Frame 223, miscellaneous RefSeqs or coded for an uncharacterized gene (DKFZp667F0711).

Finally all 26 modulated RefSeqs were clustered in a heat map (Figure 5). Although some clusters can be detected, no striking difference between the two cell line conditions can be observed.

Considering that 40,716 RefSeq transcripts were analyzed and only 26 were differently expressed, one can conclude that even this decade-long storage resulted in only minor changes to the original tumor cell line of ATCC. However, one has to take into consideration that also the ATCC clone has had to be stored for long periods of time, albeit in much better controlled conditions than in common laboratories. Thus, it is unfortunately only practically possible to compare cells to batches of ATCC’s carefully controlled ‘seed stock’, cells descending early from the original cells, but never to the cells at the time point of establishment. Cell repositories such as ATCC perform a systematic seed-stock cell-banking method, with low-passage, contaminant free and repetitively authenticated stocks in order to produce virtually identical distribution lots.

As it is not feasible to buy new cell lots for every new experiment, long term storage is a necessary evil; in this study we could demonstrate at least for BT474 cells that it is a compromise that can be made, as it affects tumor cell lines only moderately. However, also such minor changes should be carefully assessed before the start or continuation of experiments, especially if also phenotypic alterations can be observed.


Cell lines and monoclonal antibodies

BT474 cells were either obtained from ATCC (American Type Culture Collection - ATCC, Rockville, Maryland, USA; Cat. No: HTB-20®) or were stored in a liquid nitrogen tank in the lab of Prof. Dr. Thomas Grunt from the Institute for Cancer Research of the Medical University of Vienna. Prof. Grunt’s cells were cryo-conserved in 1986, which is why all experiments with these particular cells described in this paper are labeled as ‘BT474 1986’. Both BT474 cell lines were kept in α-MEM medium supplemented with 10% fetal calf serum (FCS), 2 mM l-glutamine, penicillin (100 U/mL) and streptomycin (100 μg/mL) and were grown in a humidified atmosphere of 5% CO2 at 37°C.

The anti-HER-2 monoclonal antibody trastuzumab (Herceptin®) was purchased from Roche (Hertfordshire, United Kingdom) and the anti CD20 monoclonal antibody rituximab (MabThera®, Rituxan®) likewise. Cetuximab, an anti-human EGFR antibody was purchased from Merck KGaA (Darmstadt, Germany).

As detection antibody goat anti-human IgG AlexaFluor488 (AF488, Invitrogen, Life Technologies, Grand Island, New York, USA) was employed.

Cell line authentication

Cell lines were sent for Authentication prior to all experiments to Multiplexion GmbH (Heidelberg, Germany). Cell identity was confirmed by SNP-profiling. In order to test the cells with both established cell line authentication methods, DNA was additionally sent for STR-profiling to LGC Standards (LGC Standards GmbH, Wesel, Germany) and investigated via their Power Plex® 16HS 16 Loci service.

Transmitted light microscopy

Cell culture flasks were observed under transmission light microscope (Zeiss Axio Observer Z1, Carl Zeiss AG, Jena, Germany). Pictures were acquired between cell passages 3 to 5 at 20x and 40x magnification.

Cell growth analysis

Both BT474 cell lines were seeded in 6-well plates in triplicates at a density of 0.75x105 cell/cm2, totaling 6.77x105 cells/well. After 12, 24, 48 and 70 hours, cells were harvested and measured using the TC10™ Automated Cell Counter (Bio-Rad Laboratories, Hercules, California, USA).

Flow cytometry

For the flow cytometric assessment of EGFR and HER-2 expression, single-cell suspensions of both BT474 cell lines were incubated with 200μl of either 10μg/ml cetuximab, trastuzumab or rituximab for 30 min at 4°C, followed by two washes in ice cold flow cytometry buffer (FACS-buffer, phosphate buffered saline (PBS) + 5% normal goat serum) and incubation with anti-human IgG AlexaFluor488 (AF488) antibodies (200μl of 10μg/ml, Invitrogen, Life Technologies, Grand Island, New York, USA) for 30 min at 4°C. After washing twice with ice cold FACS-buffer, samples were analyzed on a 3-laser FACSCanto™ II (BD Biosciences, Franklin Lakes, New Jersey, USA). 20,000 single cells were recorded and data was subsequently analyzed using the FlowJo V10.4 software (Tree Star, Inc., Ashland, Oregon, USA).

Cytokine, chemokine and growth factor profiling

In order to investigate the cytokine, chemokine and growth factor profile of both BT474 cell lines, cells were seeded in 6-well plates at a density of 0.75x105 cell/cm2. Supernatants were harvested after 48 hours and analyzed with the ProcartaPlexTM Human Cytokine & Chemokine Panel 1A (34 plex) immunoassay (Affymetrix, eBioscience, Thermo Fisher Scientific Inc., Vienna, Austria) according to the manufacturer’s instructions. This ProcartaPlex assay uses the Luminex® xMAP technology for the multi-analyte detection of the following 34 cytokines, chemokines and growth factors: Eotaxin, GM-CSF, GRO-α (CXCL1), IFN-α, IFN-γ, IL-10, IL-12p70, IL-13, IL-15, IL-17A, IL-18, IL-1α, IL-1β, IL-1RA (IL-1 Receptor Antagonist), IL-2, IL-21, IL-22, IL-23, IL-27, IL-31, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IP-10 (CXCL10), MCP-1 (CCL-2), Mip-1α, Mip-1β, RANTES (CCR5), SDF-1α (CXCL12α), TNF-α and TNF-β.


RNA of 3 independent biological replicates of each BT474 cell line (‘ATCC’ and ‘1986’, respectively) was isolated. Thus, cells between passage 5 and 8 were lysed and homogenized in Trizol® (Life Technologies (Invitrogen), Vienna, Austria), followed by a centrifugation step to isolate the aqueous phase containing total RNA. Subsequently, the RNA-containing solution was loaded onto RNeasy Mini spin columns (Qiagen, Hilden, Germany) and processed according to the manufacturer’s instructions. An additional on-column DNase-treatment was performed (Qiagen, Hilden, Germany). RNA yields were measured with a NanoDrop ND-1000 (Peq-lab, Erlangen, Germany). RNA quality and integrity was assessed by means of an Agilent 2100 Bioanalyzer (Agilent, Santa Clara, California, United States of America). Gene expression profiling was carried out at Atlas Biolabs (Berlin, Germany), where RNA quality was again assessed by means of Agilent 2100 Bioanalyzer (Agilent, Santa Clara, California, United States of America). Having proved good RNA quality of all samples (RIN value > 9.5; RIN = RNA Integrity Number, 1 stands for completely degraded RNA, 10 for intact RNA [30]), Expression Profiling was performed, using the GeneChip Human Gene 2.0 ST Array (Affymetrix, Santa Clara, California, United States of America), which tests 40,716 RefSeq transcripts. Sample analysis was also conducted at Atlas Biolabs. Here, quality control steps of chip data comprised of normalization and transformation in order to exclude non-biological factors (e.g. amount of stain applied) which could contribute to variability of data. Normalization was performed in order to reduce unwanted variation across chips. Thus, the input data was normalized by means of quantiles method.

After these quality control steps, gene expression data was statistically analyzed.

Data handling and statistics

Cell growth rate measurements were performed in biological triplicates. Two-way ANOVA in conjunction with Bonferroni-post test correction was performed in order to detect statistical differences between the cell growth of the two cell lines.

Flow cytometric measurements were done in 3 biological replicates and tested for statistical differences via one-way ANOVA along with Tukey’s multiple comparison test.

Cytokine expression experiments were also performed in 3 biological replicates. Data was again analyzed by means of two-way ANOVA in conjunction with Bonferroni-post test correction.

The output data of the Human Gene Arrays was computed as fold change and as log-fold change. Afterwards genes were sorted by absolute fold change. Data was analyzed by means of t-Test.

Statistic calculations were performed using GraphPad Prism 5 Software (GraphPad Software, Inc., La Jolla, California, United States of America) and statistical significance was accepted at p<0.05 (*), p<0.01 (**) and p<0.001 (***).


ATCC: American Type Culture Collection; EGFR: Epidermal Growth Factor Receptor; GM-CSF: Granulocyte Macrophage Colony-Stimulating Factor; HER-2: Human Epidermal Growth Factor Receptor-2; IL: Interleukin; TNF: Tumor Necrosis Factor; RefSeq: Reference Sequence; SNP: single nucleotide polymorphism; STR: short tandem repeat profiling


The authors would like to thank Mag. Mira Matz for excellent laboratory help and all the members of the Jensen-Jarolim lab for fruitful and inspiring discussions.


All authors declare that there is no conflict of interest with regard to this publication.


This work was supported by the Austrian Science Fund (FWF) grants P23398-B11 and W1205-B09 to EJJ.


1. Goodspeed A, Heiser LM, Gray JW, Costello JC. Tumor-Derived Cell Lines as Molecular Models of Cancer Pharmacogenomics. Mol Cancer Res. 2016; 14:3-13.

2. Negrini S, Gorgoulis VG, Halazonetis TD. Genomic instability--an evolving hallmark of cancer. Nat Rev Mol Cell Biol. 2010; 11:220-228.

3. Gillet JP, Varma S, Gottesman MM. The clinical relevance of cancer cell lines. J Natl Cancer Inst. 2013; 105:452-458.

4. Nelson-Rees WA, Owens RB, Arnstein P, Kniazeff AJ. Source, alterations, characteristics and use of a new dog cell line (Cf2Th). In Vitro. 1976; 12:665-669.

5. Nelson-Rees WA, Flandermeyer RR, Hawthorne PK. Banded marker chromosomes as indicators of intraspecies cellular contamination. Science. 1974; 184:1093-1096.

6. Nelson-Rees WA, Flandermeyer RR. Inter- and intraspecies contamination of human breast tumor cell lines HBC and BrCa5 and other cell cultures. Science. 1977; 195:1343-1344.

7. Jager W, Horiguchi Y, Shah J, Hayashi T, Awrey S, Gust KM, Hadaschik BA, Matsui Y, Anderson S, Bell RH, Ettinger S, So AI, Gleave ME, et al. Hiding in plain view: genetic profiling reveals decades old cross contamination of bladder cancer cell line KU7 with HeLa. J Urol. 2013; 190:1404-1409.

8. Geraghty RJ, Capes-Davis A, Davis JM, Downward J, Freshney RI, Knezevic I, Lovell-Badge R, Masters JR, Meredith J, Stacey GN, Thraves P, Vias M. Guidelines for the use of cell lines in biomedical research. Br J Cancer. 2014; 111:1021-1046.

9. Reid Y, Storts D, Riss T, Minor L. Authentication of Human Cell Lines by STR DNA Profiling Analysis. 2004.

10. LaFramboise T. Single nucleotide polymorphism arrays: a decade of biological, computational and technological advances. Nucleic Acids Res. 2009; 37:4181-4193.

11. Castro F, Dirks WG, Fahnrich S, Hotz-Wagenblatt A, Pawlita M, Schmitt M. High-throughput SNP-based authentication of human cell lines. Int J Cancer. 2013; 132:308-314.

12. Lovelock JE, Bishop MW. Prevention of freezing damage to living cells by dimethyl sulphoxide. Nature. 1959; 183:1394-1395.

13. Baust JG, Gao D, Baust JM. Cryopreservation: An emerging paradigm change. Organogenesis. 2009; 5:90-96.

14. Norden DM, Devine R, McCarthy DO, Wold LE. Storage Conditions and Passages Alter IL-6 secretion in C26 adenocarcinoma cell lines. MethodsX. 2015; 2:53-58.

15. Baust JM. Gene Activation of the Apoptotic Caspase Cascade Following Cryogenic Storage. Cell Preservation Technology. 2004; 1:63-80.

16. Lasfargues EY, Coutinho WG, Redfield ES. Isolation of two human tumor epithelial cell lines from solid breast carcinomas. J Natl Cancer Inst. 1978; 61:967-978.

17. Lin YZ, Li SW, Clinton GM. Insulin and epidermal growth factor stimulate phosphorylation of p185HER-2 in the breast carcinoma cell line, BT474. Mol Cell Endocrinol. 1990; 69:111-119.

18. Pasleau F, Grooteclaes M, Gol-Winkler R. Expression of the c-erbB2 gene in the BT474 human mammary tumor cell line: measurement of c-erbB2 mRNA half-life. Oncogene. 1993; 8:849-854.

19. Colbern GT, Hiller AJ, Musterer RS, Working PK, Henderson IC. Antitumor activity of Herceptin in combination with STEALTH liposomal cisplatin or nonliposomal cisplatin in a HER2 positive human breast cancer model. J Inorg Biochem. 1999; 77:117-120.

20. Arpino G, Gutierrez C, Weiss H, Rimawi M, Massarweh S, Bharwani L, De Placido S, Osborne CK, Schiff R. Treatment of human epidermal growth factor receptor 2-overexpressing breast cancer xenografts with multiagent HER-targeted therapy. J Natl Cancer Inst. 2007; 99:694-705.

21. Mohd Nafi SN, Generali D, Kramer-Marek G, Gijsen M, Strina C, Cappelletti M, Andreis D, Haider S, Li JL, Bridges E, Capala J, Ioannis R, Harris AL, et al. Nuclear HER4 mediates acquired resistance to trastuzumab and is associated with poor outcome in HER2 positive breast cancer. Oncotarget. 2014; 5:5934-49. doi: 10.18632/ oncotarget.1904.

22. Makretsov NA, Hayes M, Carter BA, Dabiri S, Gilks CB, Huntsman DG. Stromal CD10 expression in invasive breast carcinoma correlates with poor prognosis, estrogen receptor negativity, and high grade. Mod Pathol. 2007; 20:84-89.

23. Frenkel R. Regulation and physiological functions of malic enzymes. Curr Top Cell Regul. 1975; 9:157-181.

24. Loeber G, Dworkin MB, Infante A, Ahorn H. Characterization of cytosolic malic enzyme in human tumor cells. FEBS Lett. 1994; 344:181-186.

25. Stark MS, Tyagi S, Nancarrow DJ, Boyle GM, Cook AL, Whiteman DC, Parsons PG, Schmidt C, Sturm RA, Hayward NK. Characterization of the Melanoma miRNAome by Deep Sequencing. PLoS One. 2010; 5:e9685.

26. Zhu X, Zhong J, Zhao Z, Sheng J, Wang J, Liu J, Cui K, Chang J, Zhao H, Wong S. Epithelial derived CTGF promotes breast tumor progression via inducing EMT and collagen I fibers deposition. Oncotarget. 2015; 6:25320-25338. doi: 10.18632/oncotarget.4659.

27. Le Jan S, Le Meur N, Cazes A, Philippe J, Le Cunff M, Leger J, Corvol P, Germain S. Characterization of the expression of the hypoxia-induced genes neuritin, TXNIP and IGFBP3 in cancer. FEBS Lett. 2006; 580:3395-3400.

28. Bascom JL, Fata JE, Hirai Y, Sternlicht MD, Bissell MJ. Epimorphin overexpression in the mouse mammary gland promotes alveolar hyperplasia and mammary adenocarcinoma. Cancer Res. 2005; 65:8617-8621.

29. Li D, Ilnytskyy Y, Kovalchuk A, Khachigian LM, Bronson RT, Wang B, Kovalchuk O. Crucial role for early growth response-1 in the transcriptional regulation of miR-20b in breast cancer. Oncotarget. 2013; 4:1373-1387. doi: 10.18632/oncotarget.1165.

30. Imbeaud S, Graudens E, Boulanger V, Barlet X, Zaborski P, Eveno E, Mueller O, Schroeder A, Auffray C. Towards standardization of RNA quality assessment using user-independent classifiers of microcapillary electrophoresis traces. Nucleic Acids Res. 2005; 33:e56.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 16623